XML 33 R22.htm IDEA: XBRL DOCUMENT
v3.10.0.1

EARNINGS PER COMMON SHARE | 9 Months Ended
--- | ---
Sep. 30, 2018
Earnings Per Share [Abstract] |
EARNINGS PER COMMON SHARE | EARNINGS PER COMMON SHARE The following table sets forth the computation of basic and diluted earnings per share:
|  | Three months ended |  | Nine months ended
|  | September 30, |  | September 30,
(Dollars in thousands, except per share data) |  | 2018 |  | 2017 |  | 2018 |  | 2017
Numerator |  |  |  |  |  |  |  |
Net income available to common shareholders |  | $ | 50,657 |  |  | $ | 24,826 |  |  | $ | 117,581 |  |  | $ | 71,976 |
Denominator |  |  |  |  |  |  |  |
Basic earnings per common share - weighted average shares |  | 97,411,201 |  |  | 61,577,619 |  |  | 85,602,116 |  |  | 61,507,160 |
Effect of dilutive securities |  |  |  |  |  |  |  |
Employee stock awards |  | 536,760 |  |  | 552,774 |  |  | 515,566 |  |  | 617,128 |
Warrants |  | 536,267 |  |  | 59,244 |  |  | 522,245 |  |  | 61,586 |
Diluted earnings per common share - adjusted weighted average shares |  | 98,484,228 |  |  | 62,189,637 |  |  | 86,639,927 |  |  | 62,185,874 |
Earnings per share available to common shareholders |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.52 |  |  | $ | 0.40 |  |  | $ | 1.37 |  |  | $ | 1.17 |
Diluted |  | $ | 0.51 |  |  | $ | 0.40 |  |  | $ | 1.36 |  |  | $ | 1.16 |
First Financial had two warrants outstanding to purchase the Company's common stock as of September 30, 2018. The first warrant represents the right to purchase 17,172 shares of common stock at an exercise price of $12.09 per share, and expires in December 2018. The second warrant was acquired in the MSFG merger and represents the right to purchase 793,520 shares of First Financial's common stock at an exercise price of $10.71 per share and expires in January 2019. At September 30, 2017, First Financial had one warrant outstanding representing the right to purchase 105,832 shares of common stock. Stock options and warrants with exercise prices greater than the average market price of the common shares were not included in the computation of net income per diluted share, as they would have been antidilutive. Using the end of period price of the Company's common shares, there were no antidilutive options at September 30, 2018 and September 30, 2017.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration